Biofil Chemicals & Pharmaceuticals Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting
13-11-2025 | 06:56 pm
13-11-2025 | 06:56 pm
Biofil Chemicals & Pharmaceuticals approved its financial results for Q2 and H1 FY26. For Q2, net profit was ₹0.08 Cr on revenue of ₹13.60 Cr. H1 net profit stood at ₹2.49 Cr with total income of ₹22.87 Cr.
No comments yet. Be the first to comment!
All announcements from Biofil Chemicals & Pharmaceuticals Limited
